TW200637859A - Phenyl methanone derivatives - Google Patents
Phenyl methanone derivativesInfo
- Publication number
- TW200637859A TW200637859A TW095102414A TW95102414A TW200637859A TW 200637859 A TW200637859 A TW 200637859A TW 095102414 A TW095102414 A TW 095102414A TW 95102414 A TW95102414 A TW 95102414A TW 200637859 A TW200637859 A TW 200637859A
- Authority
- TW
- Taiwan
- Prior art keywords
- halogen
- lower alkyl
- hydrogen
- substituted
- cyclic amine
- Prior art date
Links
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical class O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 12
- 229910052736 halogen Inorganic materials 0.000 abstract 12
- 150000002367 halogens Chemical group 0.000 abstract 12
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000003545 alkoxy group Chemical group 0.000 abstract 5
- 150000002431 hydrogen Chemical group 0.000 abstract 5
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- -1 cyclic amine Chemical class 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100473 | 2005-01-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200637859A true TW200637859A (en) | 2006-11-01 |
Family
ID=36121826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095102414A TW200637859A (en) | 2005-01-26 | 2006-01-23 | Phenyl methanone derivatives |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7442710B2 (zh) |
| EP (1) | EP1844045B1 (zh) |
| JP (1) | JP4829900B2 (zh) |
| KR (1) | KR100915472B1 (zh) |
| CN (1) | CN101146808B (zh) |
| AR (1) | AR052662A1 (zh) |
| AT (1) | ATE447572T1 (zh) |
| AU (1) | AU2006208547B2 (zh) |
| BR (1) | BRPI0607241A2 (zh) |
| CA (1) | CA2595605A1 (zh) |
| DE (1) | DE602006010175D1 (zh) |
| ES (1) | ES2332529T3 (zh) |
| IL (1) | IL184561A (zh) |
| MX (1) | MX2007008918A (zh) |
| NO (1) | NO20073717L (zh) |
| RU (1) | RU2007126951A (zh) |
| TW (1) | TW200637859A (zh) |
| WO (1) | WO2006079467A1 (zh) |
| ZA (1) | ZA200705898B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR080375A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparacion de 2-(cicloheximetil)-n-{2-[(2s)-1-metilpirrolidin-2-il] etil}-1,2,3,4-tetrahidroisoquinolina- 7-sulfonamida |
| US9045459B2 (en) * | 2010-08-13 | 2015-06-02 | AbbVie Deutschland GmbH & Co. KG | Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| WO2016029454A1 (en) * | 2014-08-29 | 2016-03-03 | Merck Sharp & Dohme Corp. | TETRAHYDRONAPHTHYRIDINE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE |
| CN111393366B (zh) * | 2020-06-05 | 2020-09-01 | 北京华氏开元医药科技有限公司 | 四氢异喹啉类衍生物、制备方法、药物组合物及应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5017800B1 (zh) * | 1967-08-02 | 1975-06-24 | ||
| JPS5017998B1 (zh) * | 1970-06-02 | 1975-06-25 | ||
| JPS5017999B1 (zh) * | 1970-06-02 | 1975-06-25 | ||
| DE2423847A1 (de) * | 1973-05-28 | 1975-01-02 | Ciba Geigy Ag | Neue sulfamoylbenzoesaeureamide |
| DE2611705A1 (de) * | 1976-03-18 | 1977-09-22 | Josef Dipl Chem Dr Rer N Klosa | N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel |
| IT1176613B (it) | 1984-08-14 | 1987-08-18 | Ravizza Spa | Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione |
| RU2124511C1 (ru) | 1993-05-14 | 1999-01-10 | Фармасьютикал Ко., Лтд | Производные пиперазина |
| US6001854A (en) * | 1996-05-31 | 1999-12-14 | Allelix Neuroscience Inc. | Pharmaceutical for treating of neurological and neuropsychiatric disorders |
| SK13092000A3 (sk) | 1998-03-06 | 2001-03-12 | Janssen Pharmaceutica N. V. | Inhibítory prenosu glycínu, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie |
| WO1999044596A2 (en) | 1998-03-06 | 1999-09-10 | Janssen Pharmaceutica N.V. | Glycine transport inhibitors |
| CN1425008A (zh) * | 2000-01-24 | 2003-06-18 | 沃尼尔·朗伯公司 | 3－氨基喹唑啉－2,4－二酮抗菌剂 |
| AU2001254546A1 (en) | 2000-04-20 | 2001-11-07 | Nps Allelix Corp. | Aminopiperidines |
| GB0021419D0 (en) | 2000-08-31 | 2000-10-18 | Oxford Glycosciences Uk Ltd | Compounds |
| US6946474B2 (en) * | 2000-09-14 | 2005-09-20 | Merck & Co., Inc. | Nitrogen-containing compounds and their use as glycine transport inhibitors |
| WO2003004480A2 (en) | 2001-07-02 | 2003-01-16 | Novo Nordisk A/S | Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| WO2003035602A1 (en) | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Lipid modulators |
| WO2004035543A1 (en) * | 2002-10-21 | 2004-04-29 | Warner-Lambert Company Llc | Tetrahydroquinoline derivatives as crth2 antagonists |
| AU2003274053A1 (en) | 2002-10-22 | 2004-05-13 | Glaxo Group Limited | Aryloxyalkylamine derivates as h3 receptor ligands |
| EP1489071A1 (en) * | 2003-06-18 | 2004-12-22 | 4Sc Ag | N-substituted, 3,4-dihydro-1H-isoquinoline as potassium channels modulators |
| US20050070570A1 (en) * | 2003-06-18 | 2005-03-31 | 4Sc Ag | Novel potassium channels modulators |
| GB0314479D0 (en) * | 2003-06-20 | 2003-07-23 | Glaxo Group Ltd | Compounds |
| RS53252B (sr) * | 2003-08-11 | 2014-08-29 | F.Hoffmann-La Roche Ag. | Piperazin sa or-supstituisanom fenil grupom i njihova upotreba kao inhibitora glyt1 |
| DK1703909T3 (da) * | 2003-09-09 | 2009-06-22 | Hoffmann La Roche | 1-benzoyl-piperazinderivater som glycinoptagelsesinhibitorer til behandling af psykoser |
| WO2005023260A1 (en) * | 2003-09-09 | 2005-03-17 | F. Hoffmann-La Roche Ag | 1- (2-amino-benzol) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| GB0329362D0 (en) | 2003-12-18 | 2004-01-21 | Glaxo Group Ltd | Compounds |
| WO2005070893A2 (en) * | 2004-01-09 | 2005-08-04 | Corcept Therapeutics, Inc. | Azadecalin glucocorticoid receptor modulators |
| DE102004020908A1 (de) * | 2004-04-28 | 2005-11-17 | Grünenthal GmbH | Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen |
| EP1745018A1 (en) | 2004-04-29 | 2007-01-24 | Merck & Co., Inc. | Azetidine glycine transporter inhibitors |
| US7297700B2 (en) * | 2005-03-24 | 2007-11-20 | Renovis, Inc. | Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
-
2006
- 2006-01-17 AT AT06706263T patent/ATE447572T1/de active
- 2006-01-17 DE DE602006010175T patent/DE602006010175D1/de active Active
- 2006-01-17 AU AU2006208547A patent/AU2006208547B2/en not_active Ceased
- 2006-01-17 KR KR1020077019354A patent/KR100915472B1/ko not_active Expired - Fee Related
- 2006-01-17 ES ES06706263T patent/ES2332529T3/es active Active
- 2006-01-17 MX MX2007008918A patent/MX2007008918A/es active IP Right Grant
- 2006-01-17 CN CN2006800097689A patent/CN101146808B/zh not_active Expired - Fee Related
- 2006-01-17 JP JP2007552553A patent/JP4829900B2/ja not_active Expired - Fee Related
- 2006-01-17 EP EP06706263A patent/EP1844045B1/en not_active Not-in-force
- 2006-01-17 RU RU2007126951/04A patent/RU2007126951A/ru not_active Application Discontinuation
- 2006-01-17 BR BRPI0607241-0A patent/BRPI0607241A2/pt not_active IP Right Cessation
- 2006-01-17 CA CA002595605A patent/CA2595605A1/en not_active Abandoned
- 2006-01-17 WO PCT/EP2006/000361 patent/WO2006079467A1/en not_active Ceased
- 2006-01-23 TW TW095102414A patent/TW200637859A/zh unknown
- 2006-01-24 US US11/338,266 patent/US7442710B2/en not_active Expired - Fee Related
- 2006-01-26 AR ARP060100286A patent/AR052662A1/es unknown
-
2007
- 2007-07-12 IL IL184561A patent/IL184561A/en not_active IP Right Cessation
- 2007-07-18 NO NO20073717A patent/NO20073717L/no not_active Application Discontinuation
- 2007-07-18 ZA ZA200705898A patent/ZA200705898B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1844045A1 (en) | 2007-10-17 |
| ZA200705898B (en) | 2009-07-29 |
| AU2006208547B2 (en) | 2011-02-10 |
| JP2008528526A (ja) | 2008-07-31 |
| DE602006010175D1 (de) | 2009-12-17 |
| CA2595605A1 (en) | 2006-08-03 |
| AR052662A1 (es) | 2007-03-28 |
| NO20073717L (no) | 2007-08-23 |
| KR20070099030A (ko) | 2007-10-08 |
| MX2007008918A (es) | 2007-08-21 |
| BRPI0607241A2 (pt) | 2009-08-25 |
| ATE447572T1 (de) | 2009-11-15 |
| CN101146808A (zh) | 2008-03-19 |
| KR100915472B1 (ko) | 2009-09-03 |
| US20060167023A1 (en) | 2006-07-27 |
| IL184561A (en) | 2011-03-31 |
| EP1844045B1 (en) | 2009-11-04 |
| CN101146808B (zh) | 2011-10-12 |
| WO2006079467A1 (en) | 2006-08-03 |
| US7442710B2 (en) | 2008-10-28 |
| RU2007126951A (ru) | 2009-03-10 |
| ES2332529T3 (es) | 2010-02-08 |
| AU2006208547A1 (en) | 2006-08-03 |
| JP4829900B2 (ja) | 2011-12-07 |
| IL184561A0 (en) | 2007-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200634017A (en) | Bi-and tricyclic substituted phenyl methanones | |
| MX2009008465A (es) | Nuevas 2-aminooxazolinas como ligandos de taar1. | |
| JO2871B1 (en) | Perol compounds | |
| TW200639171A (en) | Heterocyclic substituted phenyl methanones | |
| TW200635585A (en) | Monocyclic substituted methanones | |
| TW200914429A (en) | Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| TW200519092A (en) | Malonamide derivatives | |
| MX2009011051A (es) | Derivados de pirrolidina como antagonistas del receptor nk1/nk3 doble. | |
| EA200701640A1 (ru) | Новые соединения с терапевтическим эффектом | |
| NO20081056L (no) | Nye, heterosykliske NF-kB-inhibitorer | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| EA200701779A1 (ru) | Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии | |
| HRP20110785T8 (en) | Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands | |
| ATE550332T1 (de) | 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors | |
| TW200510355A (en) | Benzoxazepinone derivatives | |
| TNSN08161A1 (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof | |
| JO2235B1 (en) | Derivatives of phenyl | |
| TW200637859A (en) | Phenyl methanone derivatives | |
| MY148684A (en) | Dual nk1/nk3 antagonist against schizophrenia | |
| TW200609223A (en) | Process for the preparation of n-piperidino-1,5-diphenylpyrazole-3-carboxamide derivatives | |
| ATE371661T1 (de) | Tumorhemmende derivate von et-743 | |
| ATE504583T1 (de) | 4-imidazolin-2-onverbindungen | |
| CY1108075T1 (el) | Διαδικασια για την παρασκευη αλκοξυκαρβονυλμεθοξυ-κυκλοπεντανιων | |
| NO20061604L (no) | Piperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |